Processing your request


please wait...

Case Page

 

Case Status:    ONGOING    
On or around 11/27/2019 (Date of last review)

Filing Date: November 26, 2019

According to the Complaint, Aytu BioScience, Inc. is a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs.

This action stems from Defendants’ dissemination of a proxy statement filed with the United States Securities and Exchange Commission on November 21, 2019. The Complaint alleges that the Proxy Statement omits material information, which renders the Proxy Statement false and misleading.

COMPANY INFORMATION:

Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: United States

SECURITIES INFORMATION:

Ticker Symbol: AYTU
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: D. Delaware
DOCKET #: 19-CV-02204
JUDGE: Hon. Leonard P. Stark
DATE FILED: 11/26/2019
CLASS PERIOD START: 11/21/2019
CLASS PERIOD END: 11/26/2019
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Rigrodsky & Long, P.A. (Wilmington)
  2. RM Law, P.C. (Berwyn)
No Document Title Filing Date
—Reference Complaint Complaint Related Data is not available
—Related District Court Filings Data is not available